Killestein J - Search Results

1

Plasma proteome in multiple sclerosis disease progression.

Malekzadeh A, Leurs C, van Wieringen W, Steenwijk MD, Schoonheim MM, Amann M, Naegelin Y, Kuhle J, Killestein J, Teunissen CE. Malekzadeh A, et al. Among authors: killestein j. Ann Clin Transl Neurol. 2019 Sep;6(9):1582-1594. doi: 10.1002/acn3.771. Epub 2019 Jul 31. Ann Clin Transl Neurol. 2019. PMID: 31364818 Free PMC article.

2

MS functional composite: relation to disease phenotype and disability strata.

Kalkers NF, de Groot V, Lazeron RH, Killestein J, Adèr HJ, Barkhof F, Lankhorst GJ, Polman CH. Kalkers NF, et al. Among authors: killestein j. Neurology. 2000 Mar 28;54(6):1233-9. doi: 10.1212/wnl.54.6.1233. Neurology. 2000. PMID: 10746590

3

Contrasting responses to interferon beta-1b treatment in relapsing-remitting multiple sclerosis: does baseline interleukin-12p35 messenger RNA predict the efficacy of treatment?

van Boxel-Dezaire AH, van Trigt-Hoff SC, Killestein J, Schrijver HM, van Houwelingen JC, Polman CH, Nagelkerken L. van Boxel-Dezaire AH, et al. Among authors: killestein j. Ann Neurol. 2000 Sep;48(3):313-22. doi: 10.1002/1531-8249(200009)48:3<313::aid-ana5>3.3.co;2-0. Ann Neurol. 2000. PMID: 10976637

4

Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive disease.

Killestein J, Den Drijver BF, Van der Graaff WL, Uitdehaag BM, Polman CH, Van Lier RA. Killestein J, et al. Mult Scler. 2001 Jun;7(3):145-50. doi: 10.1177/135245850100700302. Mult Scler. 2001. PMID: 11475436

5

TNFalpha production by CD4(+) T cells predicts long-term increase in lesion load on MRI in MS.

Killestein J, Kalkers NF, Meilof JF, Barkhof F, van Lier RA, Polman CH. Killestein J, et al. Neurology. 2001 Sep 25;57(6):1129-31. doi: 10.1212/wnl.57.6.1129. Neurology. 2001. PMID: 11571353

6

Antibody-mediated suppression of Vbeta5.2/5.3(+) T cells in multiple sclerosis: results from an MRI-monitored phase II clinical trial.

Killestein J, Olsson T, Wallström E, Svenningsson A, Khademi M, Blumhardt LD, Fagius J, Hillert J, Landtblom AM, Edenius C, Arfors L, Barkhof F, Polman CH. Killestein J, et al. Ann Neurol. 2002 Apr;51(4):467-74. doi: 10.1002/ana.10146. Ann Neurol. 2002. PMID: 11921052 Clinical Trial.

7

Seasonal variation in immune measurements and MRI markers of disease activity in MS.

Killestein J, Rep MH, Meilof JF, Adèr HJ, Uitdehaag BM, Barkhof F, van Lier RA, Polman CH. Killestein J, et al. Neurology. 2002 Apr 9;58(7):1077-80. doi: 10.1212/wnl.58.7.1077. Neurology. 2002. PMID: 11940696

8

Monocyte activation and disease activity in multiple sclerosis. A longitudinal analysis of serum MRP8/14 levels.

Floris S, van der Goes A, Killestein J, Knol DL, Barkhof F, Polman CH, Dijkstra CD, de Vries HE, Meilof JF. Floris S, et al. Among authors: killestein j. J Neuroimmunol. 2004 Mar;148(1-2):172-7. doi: 10.1016/j.jneuroim.2003.11.005. J Neuroimmunol. 2004. PMID: 14975598

9

No evidence of misdiagnosis in patients with multiple sclerosis and repeated positive anticardiolipin antibody testing based on magnetic resonance imaging and long term follow-up.

Liedorp M, Sanchez E, van Hoogstraten IM, von Blomberg BM, Barkhof F, Polman CH, Killestein J. Liedorp M, et al. Among authors: killestein j. J Neurol Neurosurg Psychiatry. 2007 Oct;78(10):1146-8. doi: 10.1136/jnnp.2007.117713. J Neurol Neurosurg Psychiatry. 2007. PMID: 17878195 Free PMC article.

10

Interferon beta in multiple sclerosis: predicting response at an early stage.

Killestein J, Hartung HP. Killestein J, et al. J Neurol Neurosurg Psychiatry. 2008 Jun;79(6):616-7. doi: 10.1136/jnnp.2007.138396. J Neurol Neurosurg Psychiatry. 2008. PMID: 18487553 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

308 results

Search Page